HEPATITIS B IMMUNIZATION IN THE MATERNITY WARD OF THE UNIVERSITY CLINIC FOR GYNECOLOGY AND OBSTETRICS IN R. N. MACEDONIA
Journal
Macedonian Journal of Anaesthesia
Date Issued
2024-05
Author(s)
Gjorgjevikj, Aleksandra
Duvlis, Sotirija
Abstract
Introduction: The beginning of the fight against infectious diseases is marked by receiving the
first dose of Hepatitis B (HepB) vaccine in the maternity ward. It is a recombinant viral vaccine
that stimulates active immunity. Unfortunately, on a global level, there is a decline in vaccination
coverage of children for all vaccines. Our study aims to assess the coverage of the first dose of
vaccine against the HepB among newborns in our hospital during 2023.
Material and Methods: This is a retrospective study and it included data for HepB vaccination
from all newborns born at the University Clinic for Gynecology and Obstetrics from 01.01.2023
to 31.12.2023.
Results: There were 3,917 live births in total in our maternity hospital in the year 2023. 3,235
(82.6%) of the newborns were vaccinated against the HepB virus, while 682 (17.4%) of the newborns
remained unvaccinated. In the first 24 hours after the birth and the first 7 days, 2,912 and
323 newborns were vaccinated respectively. Out of the 682 unvaccinated, 30 have been transferred
to another health facility, 8 were unvaccinated due to the written consent from the parents
for postponing vaccination, and 644 newborns remained to be vaccinated in the vaccination
dispensary, where individual calendars for immunization would be created.
Conclusion: In order not to lose the battle with infectious diseases at a time of intensive technical-
technological development, it is necessary to be more active and to continuously participate
in the process of immunization at all levels of the health care. Immunization of newborns with
HepB vaccine is an effective measure to control HepB infection and prevent liver cirrhosis and
hepatocellular carcinoma.
first dose of Hepatitis B (HepB) vaccine in the maternity ward. It is a recombinant viral vaccine
that stimulates active immunity. Unfortunately, on a global level, there is a decline in vaccination
coverage of children for all vaccines. Our study aims to assess the coverage of the first dose of
vaccine against the HepB among newborns in our hospital during 2023.
Material and Methods: This is a retrospective study and it included data for HepB vaccination
from all newborns born at the University Clinic for Gynecology and Obstetrics from 01.01.2023
to 31.12.2023.
Results: There were 3,917 live births in total in our maternity hospital in the year 2023. 3,235
(82.6%) of the newborns were vaccinated against the HepB virus, while 682 (17.4%) of the newborns
remained unvaccinated. In the first 24 hours after the birth and the first 7 days, 2,912 and
323 newborns were vaccinated respectively. Out of the 682 unvaccinated, 30 have been transferred
to another health facility, 8 were unvaccinated due to the written consent from the parents
for postponing vaccination, and 644 newborns remained to be vaccinated in the vaccination
dispensary, where individual calendars for immunization would be created.
Conclusion: In order not to lose the battle with infectious diseases at a time of intensive technical-
technological development, it is necessary to be more active and to continuously participate
in the process of immunization at all levels of the health care. Immunization of newborns with
HepB vaccine is an effective measure to control HepB infection and prevent liver cirrhosis and
hepatocellular carcinoma.
File(s)![Thumbnail Image]()
Loading...
Name
4.-HEPATITIS-B-IMMUNIZATION-IN-THE-MATERNITY-WARD-OF-THE-UNIVERSITY-CLINIC-FOR-GYNECOLOGY-AND-OBSTETRICS-Gjorgievic.pdf
Size
201.55 KB
Format
Adobe PDF
Checksum
(MD5):e648d5274da5d8be3d334ba69496d71e